Get insights on the forces of uncertainty that are shaping the landscape out to 2028 and beyond and dig into the latest Evaluate forecasts out to 2028.
We ask:
- What’s the likely impact of the Inflation Reduction Act on drug pipelines, dealmaking and pricing? And how are other regions implementing price controls?
- What commercial shifts will we see due to the IRA, FTC and the looming patent cliff?
- What are the top drugs, players and drivers of growth over the coming years?